Hsa-miR-542-3p acts as tumor suppressor by targeting survivin (BIRC5) [29, 30], the oncogene astrocyte-elevated gene-1 (MTDH) [38], or angiopoietin-2 (ANGPT2) that plays a role in tumor angiogenesis [41]. Here, BIRC5 is linked to neoplasm.